Fej-nyaki daganatok: vizsgálatok itt: Németország
51 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - 2. fázisTaking peopleA Phase II Randomized Clinical Trial Comparing Two Cycles Versus Four Cycles of Combination Therapy with Cetuximab, Avelumab, Cisplatin, and Docetaxel in Patients with Recurrent Metastatic Head and Neck Cancer - AVETUX-HN
- Where
- Aachen, Berlin, Essen, Hanover, Stuttgart
- Életkor
- 18 év and over
- People
- 126
- Run by
- Charite Universitaetsmedizin Berlin KöR
See details and how to join2025-521738-27-00 - 1/2. fázisTaking peopleAfatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
- Where
- Hanover
- Életkor
- 18 év and over
- People
- 25 worldwide
- Run by
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT06648096 · EU 2024-511477-29-00 - 3. fázisFut, nem toborozA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Augsburg, Berlin, Erlangen, Essen, Giessen, Hamburg, Straubing
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - 3. fázisTaking peopleA Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Where
- Berlin, Freiburg im Breisgau, Munich
- Életkor
- 18 év and over
- People
- 410 worldwide
- Run by
- AVEO Pharmaceuticals, Inc.
See details and how to joinNCT06064877 · EU 2023-505606-42-00 - No phaseNot yet taking people in NémetországThe Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
- Where
- Essen
- Életkor
- 18 év and over
- People
- 13 600 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05483374 - No phaseTaking peopleCarbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
- Where
- Heidelberg, Marburg
- Életkor
- 18 év and over
- People
- 72
- Run by
- University Hospital Heidelberg
See details and how to joinNCT04185974 - 2/3. fázisTaking peopleDe-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 508
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT06030440 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseNot yet taking people in NémetországNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Heidelberg
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759 - No phaseTaking peopleDe-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
- Where
- Berlin, Dresden, Essen, Frankfurt am Main, Freiburg im Breisgau, Heidelberg, München, Regensburg, Tübingen
- Életkor
- 18 év and over
- People
- 304
- Run by
- Technische Universität Dresden
See details and how to joinNCT03396718 - No phaseTaking peopleClinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT04892849 - No phaseTaking peopleTopical Application of PRF Before Radiation Therapy
- Where
- Giessen
- Életkor
- 18 év to 99 év
- People
- 34
- Run by
- University of Giessen
See details and how to joinNCT06406530 - No phaseTaking peopleSpecial Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
- Where
- Berlin, Erlangen, Frankfurt, Giessen, Halle, Jena, Kiel, Leipzig, Mainz, Munich, Würzburg
- Életkor
- 65 év and over
- People
- 1500 worldwide
- Run by
- University Hospital Freiburg
See details and how to joinNCT05337631 - No phaseTaking peopleRadiotherapy of Head and Neck Cancer With SIB
- Where
- Würzburg
- Életkor
- 18 év and over
- People
- 750
- Run by
- Wuerzburg University Hospital
See details and how to joinNCT06831903 - No phaseTaking peopleNon-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral Optoacoustic Tomography (MSOT)
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT06716892 - 2. fázisTaking peopleEuropean Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
- Where
- Cologne, Jena, Leipzig, Mannheim, München, Potsdam, Regensburg, Ulm, Würzburg
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- University of Leipzig
See details and how to joinNCT06137378 · EU 2022-502751-61-00 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Hamburg
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767 - 2. fázisTaking peoplePhase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Where
- Essen, Heidelberg
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- IO Biotech
See details and how to joinNCT05280314 - No phaseTaking peopleArtificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 250
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT05192655 - No phaseTaking peopleOnline Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 649
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT06116019 - 2. fázisNot yet taking people in NémetországIndividualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging
- Where
- Berlin, Dresden, Freiburg im Breisgau, Heidelberg, Leipzig, Mannheim, München, Würzburg
- Életkor
- 18 év and over
- People
- 276
- Run by
- Technische Universität Dresden
See details and how to joinNCT03865277 - No phaseTaking peopleImmune Biomarker Study for Head and Neck Cancer
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 1100
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT05375266 - No phaseTaking peoplePrediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
- Where
- Erlangen
- Életkor
- 18 év to 80 év
- People
- 500
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT03975322 - No phaseTaking peopleFeasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 472
- Run by
- University Hospital Tuebingen
See details and how to joinNCT04172753